Implant, Medical Implant, And Method For Delivery Of A Medical Implant
US-2024389991-A1 · Nov 28, 2024 · US
US9622753B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9622753-B2 |
| Application number | US-201414497231-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 25, 2014 |
| Priority date | Jul 20, 2001 |
| Publication date | Apr 18, 2017 |
| Grant date | Apr 18, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present application discloses an apparatus for treating vascular aneurysms and includes a radially expandable substantially cylindrical structure formed from a plurality of support members and defining a plurality of openings, and at least one reactive material strand selectively integrated into the substantially cylindrical structure. The reactive material is configured to assume a non-reacted state and a reacted state. The reactive material in the reacted state is configured to restrict a flow of blood to an aneurysm.
Opening claim text (preview).
What is claimed is: 1. An apparatus for treating vascular aneurysms, comprising: a support member forming a stent that is radially expandable to a diameter of a blood vessel; and, a reactive fiber strand encircling a portion of said support member. 2. The apparatus of claim 1 , wherein said reactive fiber strand comprises a reactive material having a reacted state that increases resistance to the flow of blood to an aneurysm. 3. The apparatus of claim 1 , wherein said reactive fiber strand comprises a hydrogel that volumetrically expands over time within the presence of blood. 4. The apparatus of claim 1 , wherein said reactive fiber strand is adhesively coupled to the support member. 5. The apparatus of claim 1 , wherein said support member has a constant diameter. 6. The apparatus of claim 1 , wherein said support member has a variable diameter. 7. The apparatus of claim 1 , wherein said support member has a variable width. 8. The apparatus of claim 1 , wherein said support member has a region of reduced width and wherein said reactive fiber strand is wrapped around said region of reduced width. 9. The apparatus of claim 8 , wherein a width of said region of reduced width and said reactive fiber strand is substantially the same as a second portion of said support member adjacent to said region of reduced width. 10. The apparatus of claim 1 , wherein a thickness of said portion of said support member and said reactive fiber strand is substantially the same as a second portion of said support member adjacent to said region of reduced width. 11. The apparatus of claim 1 , wherein said reactive fiber strand is wound so as to form gaps between each of its windings. 12. The apparatus of claim 1 , wherein said reactive fiber strand further comprises a core member of non-expansible material. 13. The apparatus of claim 1 , wherein a reactive material of said reactive fiber strand comprises a compound to promote tissue growth. 14. The apparatus of claim 1 , wherein said support member comprises a compound to promote tissue growth. 15. The apparatus of claim 1 , wherein said support member forms a zig-zag shape. 16. The apparatus of claim 1 , wherein said support member defines a shape having an internal passage. 17. The apparatus of claim 1 , further comprising a plurality of support members, wherein said reactive fiber strand is selectively wrapped around each of said plurality of support members. 18. The apparatus of claim 1 , wherein said reactive fiber strand has a thickness between about 10% and 200% of the largest thickness of said support member. 19. An apparatus for treating vascular aneurysms, comprising: a support member forming an aneurysm treatment stent that is sized for delivery within a blood vessel and expandable to a diameter of said blood vessel; and, a reactive fiber strand wound around at least a portion of said support member. 20. A method of creating a vascular treatment apparatus for aneurysms, comprising: providing a support member forming a stent sized for delivery within a human blood vessel and being expandable to a diameter of said human blood vessel; winding a reactive fiber strand around at least a portion of said support member. 21. The method of claim 20 , wherein said winding said reactive fiber strand further comprises winding said reactive fiber strand around a reduced diameter region of said support member. 22. The method of claim 20 , wherein said reactive fiber strand comprise a hydrogel that volumetrically expands over time within the presence of blood. 23. The method of claim 20 , wherein said reactive fiber strand is adhesively coupled to said support member.
Occluding by internal devices, e.g. balloons or releasable wires (plugging an opening in the wall of an organ A61B17/0057; occluders for the cervical canal A61F6/146; vas deferens occluders A61F6/20) · CPC title
Methods of manufacturing · CPC title
Winding, coiling, or depositing filamentary material (cores, formers, holders, cans or receptacles B65H75/02) · CPC title
Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus · CPC title
Growth factors · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.